WOCKHARDT
Back to Balance Sheet
|
WOCKHARDT Last 5 Year Total Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹8,138 Cr | ₹7,586 Cr | ₹7,070 Cr | ₹7,075 Cr | ₹7,670 Cr |
What is the latest Total Liabilities ratio of WOCKHARDT ?
| Year | Total Liabilities |
|---|---|
| Mar2026 | ₹8,138 Cr |
| Mar2025 | ₹7,586 Cr |
| Mar2024 | ₹7,070 Cr |
| Mar2023 | ₹7,075 Cr |
| Mar2022 | ₹7,670 Cr |
How is Total Liabilities of WOCKHARDT Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹8,138 Cr | 7.28 | |
| Mar2025 | ₹7,586 Cr | 7.30 | |
| Mar2024 | ₹7,070 Cr | -0.07 | |
| Mar2023 | ₹7,075 Cr | -7.76 | |
| Mar2022 | ₹7,670 Cr | - | |
Compare Total Liabilities of peers of WOCKHARDT
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| WOCKHARDT | ₹30,554.1 Cr | 2.7% | -0.4% | 27.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹456,114.0 Cr | NA | -3.9% | 17.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹239,321.0 Cr | 5% | 21.5% | 44.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹185,924.0 Cr | -2.1% | -0.2% | 34.3% | Stock Analytics | |
| CIPLA | ₹113,778.0 Cr | -2% | -2.5% | -8.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,025.9 Cr | 0.4% | 4.5% | -4.4% | Stock Analytics | |
WOCKHARDT Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| WOCKHARDT | 2.7% |
-0.4% |
27.6% |
| SENSEX | 0.7% |
0.8% |
-5.1% |
You may also like the below Video Courses